Wednesday, July 8, 2026

Drug profile · INN

sodium phosphate, dibasic, anhydrous

sodium phosphate, dibasic, anhydrous (MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE) is a saline laxative. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — sodium phosphate, dibasic, anhydrous
US status
approved
Class
Route
ORAL
Patents
0
Programs
1
Data quality
0.84

Quick answer

sodium phosphate, dibasic, anhydrous (MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE) is a saline laxative. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN sodium phosphate, dibasic, anhydrous
Brand MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE
Mechanism Saline laxative
Route ORAL
Formulation TABLET

Mechanism of action

Saline laxative

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. UIC-STP-2017 Phase 3 · Universal Integrated · Bowel Preparation

Frequently asked questions

What is sodium phosphate, dibasic, anhydrous?

sodium phosphate, dibasic, anhydrous (MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE) is a saline laxative. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for sodium phosphate, dibasic, anhydrous?

MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE is a marketed brand name for sodium phosphate, dibasic, anhydrous. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium phosphate, dibasic, anhydrous?

sodium phosphate, dibasic, anhydrous has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.